查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829414

2025年全球生物晶片市場報告

Biochips Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，生物晶片市場規模快速擴張，從2024年的126.2億美元成長到2025年的146.1億美元，複合年成長率達15.7%。這段歷史時期的成長可歸因於個人化醫療需求的不斷成長、慢性病的高發病率、技術創新、藥物研發應用的不斷擴展、研發投入的不斷增加以及支持性法律規範的完善。

預計未來幾年生物晶片市場規模將快速成長，到2029年將達到257.8億美元，複合年成長率為15.2%。預測期內的成長機會可歸因於照護現場應用的日益普及、藥物開發應用的不斷擴展、個人化醫療需求的不斷成長、微流體技術的進步、研發投入的不斷增加、生物技術公司與學術機構之間合作的不斷加強，以及農業生物技術領域的新興機遇。預測期內的主要趨勢包括：微流體技術的進步、對用於液態切片應用的生物晶片開發的日益重視、對用於同時檢測多種分析物的多重檢測的需求不斷成長、人工智慧在數據分析中的應用以及新型生物晶片平台的湧現。

生物晶片是一種微型裝置，將DNA、蛋白質和細胞等生物材料附著在固體表面上。生物晶片將生物元件與電子系統結合，用於研究和操作生物數據，廣泛應用於醫療診斷、基因序列測定和其他生物技術領域。

生物晶片的主要類型包括DNA晶片（或DNA微陣列）、蛋白質晶片、實驗室晶片系統、組織陣列和細胞陣列。 DNA晶片利用微陣列和微射流等技術，能夠同時分析大量基因的表現。這些生物晶片應用於藥物研發、農業、基因組學、疾病診斷和蛋白質組學，並被各種終端用戶使用，包括生物技術公司、製藥公司、學術機構、醫院和診斷中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供生物晶片市場統計數據，例如生物晶片行業的全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的生物晶片細分市場、市場趨勢和商業機會，以及您在生物晶片行業取得成功所需的數據。本生物晶片市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

我們預測未來五年該市場將成長15.2%，較先前預測略有下降1.1%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國，導致來自台灣、韓國和日本等主要地區的高純度矽晶圓和微流體基板供應鏈中斷，從而導致生產延遲以及基因組和診斷測試成本上升。此外，這種影響可能會透過互惠關稅以及不斷升級的貿易緊張局勢和限制對全球經濟和貿易的負面影響，更廣泛地顯現出來。

個人化醫療的日益普及預計將推動生物晶片市場的成長。個人化醫療旨在根據個人特徵（例如遺傳和生活習慣）客製化治療方案，以最佳化療效並最大程度地減少副作用。推動這一趨勢的因素包括：個人化醫療有望提供更有效的治療方案；基因組學的進步；疾病的日益複雜化；以及監管環境的變化。生物晶片在個人化醫療中發揮關鍵作用，它能夠根據個人基因圖譜制定精準的個人化治療方案。例如，2024年2月，美國食品藥物管理局（FDA）核准了16種針對罕見疾病的新型個人化療法，凸顯了個人化醫療的蓬勃發展動能及其對生物晶片市場的影響。

生物晶片市場的主要企業正專注於開發最尖端科技，例如器官晶片平台，以改變藥物發現和開發流程。器官晶片平台是一種先進的微流體裝置，旨在小規模模擬人體器官的生理特性和功能。例如，2024年4月，波士頓微製造公司（BMF）推出了BMF生物技術公司，專門研發用於試管內培養大規模組織的生物晶片和器官晶片平台。這項進展將透過提供體外測試和研究平台來加速藥物和化妝品的開發。

2023年6月，朗道實驗室收購了Cellix有限公司，增強了其在台式流式細胞技術領域的專業知識，並致力於改善個人化醫療和預防性醫療保健。此次收購擴展了朗道的產品組合，使更多研究人員和醫療保健專業人士能夠使用流式細胞技術技術。總部位於愛爾蘭的Cellix有限公司專注於為生命科學領域的各種應用開發生物晶片。

生物晶片市場包括實驗室晶片(LOC) 設備、細胞微陣列和蛋白質微陣列的銷售。該市場的價值指的是“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生物晶片：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球生物晶片市場：成長率分析
  • 全球生物晶片市場表現：規模與成長，2019-2024
  • 全球生物晶片市場預測：規模與成長，2024-2029年，2034年
  • 全球生物晶片：總目標市場（TAM）

第6章 市場細分

  • 全球生物晶片市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）晶片
  • 蛋白質晶片
  • 實驗室晶片
  • 組織陣列
  • 細胞陣列
  • 全球生物晶片市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 微陣列
  • 微流體
  • 全球生物晶片市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發
  • 農業
  • 基因組學
  • 疾病診斷
  • 蛋白質體學
  • 其他用途
  • 全球生物晶片市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物技術和製藥公司
  • 學術研究機構
  • 醫院和診斷中心
  • 其他最終用戶
  • 全球生物晶片市場：依去氧核糖核酸(DNA) 晶片類型細分，現況及預測，2019-2024 年、2024-2029 年、2034 年
  • 基因表現晶片
  • SNP（單核苷酸多態性）晶片
  • DNA微陣列
  • 全球生物晶片市場：蛋白質晶片細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 抗體陣列
  • 蛋白質微陣列
  • 胜肽陣列
  • 全球生物晶片市場：晶片實驗室晶片（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 微流體設備
  • 生物感測器
  • 全球生物晶片市場：按組織陣列細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 腫瘤組織晶片
  • 正常組織陣列
  • 全球生物晶片市場：依細胞陣列類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 基於細胞的生物晶片
  • 細胞訊號傳導陣列

第7章 區域和國家分析

  • 全球生物晶片市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球生物晶片市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 生物晶片市場：競爭格局
  • 生物晶片市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Tecan Group Ltd.
  • Cepheid Inc.
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Oxford Nanopore Technologies plc
  • Luminex Corporation
  • Fluidigm Corporation
  • Micronit Microtechnologies BV
  • Sphere Fluidics Limited
  • Sengenics
  • Arrayit Corporation
  • CustomArray Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年生物晶片市場：提供新機會的國家
  • 2029年生物晶片市場：細分市場帶來新機會
  • 2029年生物晶片市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29592u

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $12.62 billion in 2024 to $14.61 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to increased demand for personalized medicine, high prevalence of chronic diseases, technological innovations, expanded applications in drug discovery, growth in investments in research and development, and supportive regulatory frameworks.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $25.78 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to increasing adoption in point-of-care diagnostics, expanding applications in drug development, rising demand for personalized medicine, advancements in microfluidics technology, growing investments in research and development, expanding collaborations between biotechnology companies and academic institutions, and emerging opportunities in agricultural biotechnology. Major trends in the forecast period include advancements in microfluidics technology, emphasis on developing biochips for liquid biopsy applications, rising demand for multiplexed assays for simultaneous detection of multiple analytes, integration of artificial intelligence for data analysis, and the emergence of novel biochip platforms.

The forecast of 15.2% growth over the next five years reflects a modest reduction of 1.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for high-purity silicon wafers and microfluidic substrates, sourced from key regions such as Taiwan, South Korea, and Japan, which could lead to production delays and increased costs for genomic and diagnostic testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
  • 2) By Technology: Microarrays; Microfluidics
  • 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
  • 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
  • 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
  • 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
  • 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
  • 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Zoetis Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Cepheid Inc.; Randox Laboratories Ltd.; Takara Bio Inc.; Oxford Nanopore Technologies plc; Luminex Corporation; Fluidigm Corporation; Micronit Microtechnologies B.V.; Sphere Fluidics Limited; Sengenics; Arrayit Corporation; CustomArray Inc.; Partek Incorporated; NanoCellect Biomedical Inc.; Dolomite Microfluidics; Biocartis NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biochips Market Characteristics

3. Biochips Market Trends And Strategies

4. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biochips Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biochips Market Growth Rate Analysis
  • 5.4. Global Biochips Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biochips Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biochips Total Addressable Market (TAM)

6. Biochips Market Segmentation

  • 6.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Chips
  • Protein Chips
  • Lab-On-Chip
  • Tissue Arrays
  • Cell Arrays
  • 6.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarrays
  • Microfluidics
  • 6.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Agriculture
  • Genomics
  • Disease Diagnostics
  • Proteomics
  • Other Applications
  • 6.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biotechnology And Pharmaceutical Companies
  • Academic And Research Institutes
  • Hospitals And Diagnostic Centers
  • Other End-Users
  • 6.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Expression Chips
  • SNP (Single Nucleotide Polymorphism) Chips
  • DNA Microarrays
  • 6.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibody Arrays
  • Protein Microarrays
  • Peptide Arrays
  • 6.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfluidic Devices
  • Biosensors
  • 6.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Tissue Arrays
  • Normal Tissue Arrays
  • 6.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell-Based Biochips
  • Cell Signaling Arrays

7. Biochips Market Regional And Country Analysis

  • 7.1. Global Biochips Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biochips Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biochips Market

  • 8.1. Asia-Pacific Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biochips Market

  • 9.1. China Biochips Market Overview
  • 9.2. China Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biochips Market

  • 10.1. India Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biochips Market

  • 11.1. Japan Biochips Market Overview
  • 11.2. Japan Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biochips Market

  • 12.1. Australia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biochips Market

  • 13.1. Indonesia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biochips Market

  • 14.1. South Korea Biochips Market Overview
  • 14.2. South Korea Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biochips Market

  • 15.1. Western Europe Biochips Market Overview
  • 15.2. Western Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biochips Market

  • 16.1. UK Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biochips Market

  • 17.1. Germany Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biochips Market

  • 18.1. France Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biochips Market

  • 19.1. Italy Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biochips Market

  • 20.1. Spain Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biochips Market

  • 21.1. Eastern Europe Biochips Market Overview
  • 21.2. Eastern Europe Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biochips Market

  • 22.1. Russia Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biochips Market

  • 23.1. North America Biochips Market Overview
  • 23.2. North America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biochips Market

  • 24.1. USA Biochips Market Overview
  • 24.2. USA Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biochips Market

  • 25.1. Canada Biochips Market Overview
  • 25.2. Canada Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biochips Market

  • 26.1. South America Biochips Market Overview
  • 26.2. South America Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biochips Market

  • 27.1. Brazil Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biochips Market

  • 28.1. Middle East Biochips Market Overview
  • 28.2. Middle East Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biochips Market

  • 29.1. Africa Biochips Market Overview
  • 29.2. Africa Biochips Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biochips Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biochips Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biochips Market Competitive Landscape And Company Profiles

  • 30.1. Biochips Market Competitive Landscape
  • 30.2. Biochips Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biochips Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Tecan Group Ltd.
  • 31.5. Cepheid Inc.
  • 31.6. Randox Laboratories Ltd.
  • 31.7. Takara Bio Inc.
  • 31.8. Oxford Nanopore Technologies plc
  • 31.9. Luminex Corporation
  • 31.10. Fluidigm Corporation
  • 31.11. Micronit Microtechnologies B.V.
  • 31.12. Sphere Fluidics Limited
  • 31.13. Sengenics
  • 31.14. Arrayit Corporation
  • 31.15. CustomArray Inc.

32. Global Biochips Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biochips Market

34. Recent Developments In The Biochips Market

35. Biochips Market High Potential Countries, Segments and Strategies

  • 35.1 Biochips Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biochips Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biochips Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer